153 related articles for article (PubMed ID: 37517056)
21. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
[No Abstract] [Full Text] [Related]
22. Para-aortic lymph nodes and ductal adenocarcinoma of the pancreas: Distant neighbors?
Safi SA; Rehders A; Haeberle L; Fung S; Lehwald N; Esposito I; Ziayee F; Krieg A; Knoefel WT; Fluegen G
Surgery; 2021 Dec; 170(6):1807-1814. PubMed ID: 34392977
[TBL] [Abstract][Full Text] [Related]
23. Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of abdominal radiology disease focus panel on PDAC.
Chu LC; Wang ZJ; Kambadakone A; Hecht EM; He J; Narang AK; Laheru DA; Arif-Tiwari H; Bhosale P; Bolan CW; Brook OR; Bezuidenhout AF; Do RKG; Galgano SJ; Goenka AH; Guimaraes AR; Hough DM; Kulkarni N; Le O; Luk L; Mannelli L; Rosenthal M; Sangster G; Shah ZK; Soloff EV; Tolat PP; Zins M; Fishman EK; Tamm EP; Zaheer A
Abdom Radiol (NY); 2023 Jan; 48(1):318-339. PubMed ID: 36241752
[TBL] [Abstract][Full Text] [Related]
24. Elevated Preoperative DUPAN-2 Level Predicts Locoregional Recurrence After Pancreatectomy in Patients With Pancreatic Ductal Adenocarcinoma.
Sasaki A; Inokuchi S; Tsutsumi S; Futsukaichi T; Terashi T; Ikebe M; Bandoh T; Utsunomiya T
Anticancer Res; 2022 Apr; 42(4):2071-2078. PubMed ID: 35347030
[TBL] [Abstract][Full Text] [Related]
25. Pathologic Subtypes of Ampullary Adenocarcinoma: Value of Ampullary MDCT for Noninvasive Preoperative Differentiation.
Ivanovic AM; Alessandrino F; Maksimovic R; Micev M; Ostojic S; Gore RM; Mortele KJ
AJR Am J Roentgenol; 2017 Mar; 208(3):W71-W78. PubMed ID: 28095024
[TBL] [Abstract][Full Text] [Related]
26. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.
Asagi A; Ohta K; Nasu J; Tanada M; Nadano S; Nishimura R; Teramoto N; Yamamoto K; Inoue T; Iguchi H
Pancreas; 2013 Jan; 42(1):11-9. PubMed ID: 22699206
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of diagnostic utility of multidetector computed tomography and magnetic resonance imaging in blunt pancreatic trauma: a prospective study.
Panda A; Kumar A; Gamanagatti S; Bhalla AS; Sharma R; Kumar S; Mishra B
Acta Radiol; 2015 Apr; 56(4):387-96. PubMed ID: 24760286
[TBL] [Abstract][Full Text] [Related]
28. Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery.
Kim TH; Song TJ; Lee SO; Park CH; Moon JH; Pih GY; Oh DW; Woo SM; Yang YJ; Kim MH
Pancreatology; 2019 Dec; 19(8):1054-1060. PubMed ID: 31611130
[TBL] [Abstract][Full Text] [Related]
29. Factors predicting recurrence after resection of pancreatic ductal carcinoma.
Shibata K; Matsumoto T; Yada K; Sasaki A; Ohta M; Kitano S
Pancreas; 2005 Jul; 31(1):69-73. PubMed ID: 15968250
[TBL] [Abstract][Full Text] [Related]
30. Role of rapid kV-switching dual-energy CT in assessment of post-surgical local recurrence of pancreatic adenocarcinoma.
Parakh A; Patino M; Muenzel D; Kambadakone A; Sahani DV
Abdom Radiol (NY); 2018 Feb; 43(2):497-504. PubMed ID: 29138890
[TBL] [Abstract][Full Text] [Related]
31. Invasive intraductal papillary mucinous neoplasms of the pancreas: relationships between mural nodules detected on thin-section contrast-enhanced MDCT and invasive components.
Kamei N; Yamada Y; Hijiya N; Takaji R; Kiyonaga M; Hongo N; Ohta M; Hirashita T; Inomata M; Matsumoto S
Abdom Radiol (NY); 2019 Sep; 44(9):3139-3147. PubMed ID: 31168723
[TBL] [Abstract][Full Text] [Related]
32. CT texture analysis for the presurgical prediction of superior mesenteric-portal vein invasion in pancreatic ductal adenocarcinoma: comparison with CT imaging features.
Chen F; Zhou Y; Qi X; Xia W; Zhang R; Zhang J; Gao X; Zhang L
Clin Radiol; 2021 May; 76(5):358-366. PubMed ID: 33581837
[TBL] [Abstract][Full Text] [Related]
33. Bile duct angulation and tumor vascularity are useful radiographic features for differentiating pancreatic head cancer and intrapancreatic bile duct cancer.
Kohga A; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Aramaki T; Sasaki K; Uesaka K
Surg Today; 2018 Jul; 48(7):673-679. PubMed ID: 29460125
[TBL] [Abstract][Full Text] [Related]
34. Differential diagnosis of pancreatic cancer from other solid tumours arising from the periampullary area on MDCT.
Jang SK; Kim JH; Joo I; Jeon JH; Shin KS; Han JK; Choi BI
Eur Radiol; 2015 Oct; 25(10):2880-8. PubMed ID: 25916385
[TBL] [Abstract][Full Text] [Related]
35. Intraductal papillary mucinous neoplasms of the pancreas: CT patterns of recurrence and multiobserver performance in detecting recurrent neoplasm after surgical resection.
Christensen JA; Fletcher JG; Fidler JL; Wold PB; Binstock AJ; Smyrk T; Harmsen SW; Crownhart BS; Chari S
AJR Am J Roentgenol; 2004 Nov; 183(5):1367-74. PubMed ID: 15505305
[TBL] [Abstract][Full Text] [Related]
36. Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival.
Sala E; Kataoka M; Pandit-Taskar N; Ishill N; Mironov S; Moskowitz CS; Mironov O; Collins MA; Chi DS; Larson S; Hricak H
Radiology; 2010 Oct; 257(1):125-34. PubMed ID: 20697116
[TBL] [Abstract][Full Text] [Related]
37. Use of EUS-FNA in diagnosing pancreatic neoplasm without a definitive mass on CT.
Wang W; Shpaner A; Krishna SG; Ross WA; Bhutani MS; Tamm EP; Raju GS; Xiao L; Wolff RA; Fleming JB; Lee JH
Gastrointest Endosc; 2013 Jul; 78(1):73-80. PubMed ID: 23523302
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic Duct Involvement in Well-Differentiated Neuroendocrine Tumors is an Independent Poor Prognostic Factor.
Nanno Y; Matsumoto I; Zen Y; Otani K; Uemura J; Toyama H; Asari S; Goto T; Ajiki T; Okano K; Suzuki Y; Takeyama Y; Fukumoto T; Ku Y
Ann Surg Oncol; 2017 Apr; 24(4):1127-1133. PubMed ID: 27822631
[TBL] [Abstract][Full Text] [Related]
39. Small pancreatic ductal carcinomas on triple-phase contrast-enhanced computed tomography: enhanced rims and the pathologic correlation.
Takaji R; Yamada Y; Matsumoto S; Kiyonaga M; Hongo N; Mori H; Hijiya N; Ohta M; Inomata M; Takaki H; Fukuzawa K; Yonemasu H
Abdom Radiol (NY); 2018 Dec; 43(12):3374-3380. PubMed ID: 29796845
[TBL] [Abstract][Full Text] [Related]
40. Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter Study.
Postlewait LM; Ethun CG; McInnis MR; Merchant N; Parikh A; Idrees K; Isom CA; Hawkins W; Fields RC; Strand M; Weber SM; Cho CS; Salem A; Martin RC; Scoggins C; Bentrem D; Kim HJ; Carr J; Ahmad S; Abbott DE; Wilson GC; Kooby DA; Maithel SK
JAMA Surg; 2017 Jan; 152(1):19-25. PubMed ID: 27760255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
